Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Linus Maximilian Risser

2PUBLICATIONS

18CO-AUTHORS

Clinical pharmacology and therapeutics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Apr 15, 2025

Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR database.

Linus Maximilian Risser, Torsten Witte, Matthias Englbrecht

|Aug 13, 2024

Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network.

Patrick-Pascal Strunz, Matthias Englbrecht, Linus Maximilian Risser

Pageof 1

Frequent Collaborators

2 joint publications

Patrick-Pascal Strunz

2 joint publications

Matthias Englbrecht

2 joint publications

Torsten Witte

2 joint publications

Matthias Froehlich

2 joint publications

Marc Schmalzing

2 joint publications

Michael Gernert

2 joint publications

Stefan Kleinert

2 joint publications

Peter Bartz-Bazzanella

2 joint publications

Cay von der Decken

2 joint publications

Kirsten Karberg

Frequent Collaborators

2 joint publications

Patrick-Pascal Strunz

2 joint publications

Matthias Englbrecht

2 joint publications

Torsten Witte

2 joint publications

Matthias Froehlich

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

See more related videos

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

See more related videos